secwatch.observer — SEC 8-K summary
======================================

Issuer:     NUTRA PHARMA CORP (—)
CIK:        0001119643
Form:       8-K
Filed at:   2025-09-03T23:59:59+00:00
Accession:  0001641172-25-026384
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Nutra Pharma Corp. changes certifying accountant: Marcum LLP resigns, Astra Audit & Advisory engaged
--------------------------------------------------------------------------------

- Marcum LLP resigned as independent auditor on March 27, 2024, after only reviewing Q2 and Q3 2022 Form 10-Qs.
- No disagreements occurred, but Marcum cited material weaknesses including lack of qualified accounting personnel and inadequate segregation of duties.
- Astra Audit & Advisory was engaged on December 18, 2024, as new independent registered public accounting firm for FY 2022.
- The Company provided Marcum with disclosures; Marcum's letter to the SEC dated September 3, 2025, is filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1119643/000164117225026384/0001641172-25-026384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1119643/000164117225026384/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer